Literature DB >> 20337335

Melkersson-Rosenthal Syndrome Presenting as Chronic Eyelid Swelling.

Svetlana Kondratiev, Katrinka Heher, Brad J Baker, Nora V Laver.   

Abstract

Melkersson-Rosenthal Syndrome (MRS) is a rare disorder characterized by orofacial edema, facial palsy, and fissured tongue. A 64-year-old man presented with a fissured tongue and persistent chronic right upper eyelid edema of 15 years duration. The diagnostic biopsy revealed non-necrotizing granulomatous inflammation adjacent to blood and lymphatic vessels. Characteristic granulomas with focal occlusion of dilated lymphatic channels were present. Special stains for fungi, acid-fast microorganisms and bacteria were negative. Ptosis due to a mechanical effect of the persistent eyelid edema required surgical treatment including debulking and advancement of the levator muscle. At 6 months after surgery the patient showed symmetrical eyelid position without edema. The case demonstrates an uncommon presentation of Melkersson-Rosenthal syndrome with prominent upper eyelid edema and lingua plicata, which was initially misdiagnosed. The clinical findings coupled with the characteristic granulomatous lymphangitis present in the biopsy are crucial for a definite diagnosis. Copyright 2010, SLACK Incorporated.

Entities:  

Year:  2010        PMID: 20337335     DOI: 10.3928/15428877-20100215-36

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  3 in total

1.  A 49-year-old man with unilateral, nontender left eyelid swelling.

Authors:  Brandon J Wong; Bryan K Hong; Daman Samrao; Gene H Kim; Narsing A Rao
Journal:  Digit J Ophthalmol       Date:  2014-01-18

2.  Orofacial granulomatosis presenting as bilateral eyelid swelling.

Authors:  Curtis W Archibald; Karim G Punja; Allan F Oryschak
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

3.  Melkerrson-Rosenthal Syndrome, a rare case report of chronic eyelid swelling.

Authors:  Babita Kajal; John Harvey; Salem Alowami
Journal:  Diagn Pathol       Date:  2013-11-13       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.